Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei
Authors:
- 1 October 2012
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 38 (10) , 962-968
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Survival of patients with pseudomyxoma peritonei treated by serial debulkingColorectal Disease, 2010
- Appendiceal neoplasms and pseudomyxoma peritonei: A population based studyEuropean Journal of Surgical Oncology, 2008
- Long-term Survival Following Treatment of Pseudomyxoma PeritoneiAnnals of Surgery, 2005
- Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma PeritoneiAnnals of Surgical Oncology, 2004
- Molecular Genetic Evidence Supporting the Clonality and Appendiceal Origin of Pseudomyxoma Peritonei in WomenThe American Journal of Pathology, 1999
- A Clinicopathologic Analysis of 109 Cases with Emphasis on Distinguishing Pathologic Features, Site of Origin, Prognosis, and Relationship to “Pseudomyxoma Peritonei”American Journal of Surgical Pathology, 1995
- Pseudomyxoma Peritonei Long-Term Patient Survival with an Aggressive Regional ApproachAnnals of Surgery, 1994
- Pseudomyxoma Peritonei A Cancer Whose Biology Is Characterized by a Redistribution PhenomenonAnnals of Surgery, 1994
- Malignant pseudomyxoma peritonei of colonic originDiseases of the Colon & Rectum, 1987
- Pseudomyxoma PeritoneiJournal of the Royal Society of Medicine, 1986